The immune system of mouse vibrissae follicles: Cellular composition and indications of immune privilege

Experimental Dermatology

Volumn 22, Issue 9, 2013, Pages 593-598

  Bertolini, Marta ^a   Meyer, Katja C ^a   Slominski, Radomir ^b   Kobayashi, Ken ^c   Ludwig, Ralf J ^a   Paus, Ralf ^a,d  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c HOKKAIDO UNIVERSITY   (Japan)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Follicle sinus hair; Immune privilege; Immune system; Vibrissae hair follicle; Whisker

Indexed keywords

CD11B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPOSITION; CONNECTIVE TISSUE; DOWN REGULATION; FEMALE; GAMMA DELTA T LYMPHOCYTE; HAIR FOLLICLE; HAIR GROWTH; HUMAN; IMMUNE SYSTEM; IMMUNOBIOLOGY; IMMUNOPHENOTYPING; LANGERHANS CELL; MACROPHAGE; MAST CELL; MORPHOMETRICS; MOUSE; NONHUMAN; VIBRISSA;

EID: 84882254347     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12205     Document Type: Article

References (91)

1. Vincent S B. J Comp Neurol 1913: 23: 1-34.
2. Ahl A S. Vet Res Commun 1986: 10: 245-268.
3. Rice F L, Munger B L. J Comp Neurol 1986: 252: 186-205.
4. Sarko D K, Rice F L, Reep R L. Ann N Y Acad Sci 2011: 1225: 90-100.
5. Jahoda C A, Horne K A, Oliver R F. Nature 1984: 311: 560-562.
6. Jahoda C A, Reynolds A J. J Invest Dermatol 1993: 101: 33S-38S.
7. Higgins C A, Richardson G D, Westgate G E et al. Exp Dermatol 2009: 18: 793-795.
8. Iida M, Ihara S, Matsuzaki T. Differentiation 2007: 75: 371-381.
9. Oshima H, Rochat A, Kedzia C et al. Cell 2001: 104: 233-245.
10. Waters J M, Lindo J E, Arkell R M et al. J Invest Dermatol 2011: 131: 838-847.
11. Hwang K A, Hwang Y L, Lee M H et al. Int J Mol Med 2012: 29: 195-201.
12. Erzurumlu R S, Murakami Y, Rijli F M. Nat Rev Neurosci 2010: 11: 252-263.
13. Kleinfeld D, Deschenes M. Neuron 2011: 72: 455-468.
14. Lo F S, Erzurumlu R S. J Neurophysiol 2011: 105: 1681-1688.
15. Takata N, Mishima T, Hisatsune C et al. J Neurosci 2011: 31: 18155-18165.
16. Kobayashi K, Rochat A, Barrandon Y. Proc Natl Acad Sci USA 1993: 90: 7391-7395.
17. Lako M, Armstrong L, Cairns P M et al. J Cell Sci 2002: 115: 3967-3974.
18. Meyer-Blazejewska E A, Call M K, Yamanaka O et al. Stem Cells 2011: 29: 57-66.
19. Nagoshi N, Shibata S, Kubota Y et al. Cell Stem Cell 2008: 2: 392-403.
20. Fantauzzo K A, Christiano A M. Development 2012: 139: 203-214.
21. Halata Z. J Invest Dermatol 1993: 101: 75S-81S.
22. Lee J, Wu W, Kopan R. J Invest Dermatol 2008: 128: 482-485.
23. Robinson M, Reynolds A J, Jahoda C A. J Invest Dermatol 1997: 108: 495-500.
24. Davidson P, Hardy M H. J Anat 1952: 86: 342-356.
25. Dorfl J. J Anat 1982: 135: 147-154.
26. Kim J N, Koh K S, Lee E et al. Cells Tissues Organs 2011: 193: 207-214.
27. Melaragno H P, Montagna W. Anat Rec 1953: 115: 129-149.
28. Sundberg J P, Peters E M, Paus R. J Investig Dermatol Symp Proc 2005: 10: 264-270.
29. Yung R D, Oliver R F. J Embryol exp Morph 1976: 36: 597-607.
30. Botchkarev V A, Eichmuller S, Johansson O et al. J Comp Neurol 1997: 386: 379-395.
31. Botchkarev V A, Eichmuller S, Peters E M et al. Arch Dermatol Res 1997: 289: 292-302.
32. Maklad A, Fritzsch B, Hansen L A. Cell Tissue Res 2004: 315: 167-180.
33. Moll I, Paus R, Moll R. J Invest Dermatol 1996: 106: 281-286.
34. Peters E M, Botchkarev V A, Muller-Rover S et al. J Comp Neurol 2002: 448: 28-52.
35. Rice F L, Fundin B T, Arvidsson J et al. J Comp Neurol 1997: 385: 149-184.
36. Fundin B T, Pfaller K, Rice F L. J Comp Neurol 1997: 389: 545-568.
37. Fan H, Lin Q, Morrissey G R et al. Nat Biotechnol 1999: 17: 870-872.
38. Fujisaki J, Wu J, Carlson A L et al. Nature 2011: 474: 216-219.
39. Hoffman R M. Mol Ther 2003: 7: 294-295.
40. Nagao K, Kobayashi T, Moro K et al. Nat Immunol 2012: 13: 744-752.
41. Tobin D J. Br J Dermatol 1998: 138: 795-798.
42. Eichmuller S, Van der Veen C, Moll I et al. J Histochem Cytochem 1998: 46: 361-370.
43. Kloepper J E, Kawai K, Bertolini M et al. J Invest Dermatol 2013: 133: 1666-1669.
44. Paus R, Eichmuller S, Hofmann U et al. Br J Dermatol 1994: 131: 177-183.
45. Paus R, Hofmann U, Eichmuller S et al. Br J Dermatol 1994: 130: 281-289.
46. Paus R, Maurer M, Slominski A et al. Dev Biol 1994: 163: 230-240.
47. Paus R, Nickoloff B J, Ito T. Trends Immunol 2005: 26: 32-40.
48. Paus R, van der Veen C, Eichmuller S et al. J Invest Dermatol 1998: 111: 7-18.
49. Rosenblum M D, Olasz E B, Yancey K B et al. J Invest Dermatol 2004: 123: 880-887.
50. Rosenblum M D, Yancey K B, Olasz E B et al. J Dermatol Sci 2006: 41: 165-174.
51. Ruckert R, Hofmann U, van der Veen C et al. J Invest Dermatol 1998: 111: 25-30.
52. Kumamoto T, Shalhevet D, Matsue H et al. Blood 2003: 102: 1654-1660.
53. Ito N, Sugawara K, Bodo E et al. J Invest Dermatol 2010: 130: 995-1004.
54. Sugawara K, Biro T, Tsuruta D et al. J Allergy Clin Immunol 2012: 129: 726-738 e728.
55. Maurer M, Fischer E, Handjiski B et al. Lab Invest 1997: 77: 319-332.
56. Larouche D, Tong X, Fradette J et al. FASEB J 2008: 22: 1404-1415.
57. Mellor A L, Munn D H. Nat Rev Immunol 2008: 8: 74-80.
58. Wahl S M, Wen J, Moutsopoulos N. Immunol Rev 2006: 213: 213-227.
59. Forrester J V, Xu H, Lambe T et al. Mucosal Immunol 2008: 1: 372-381.
60. Meyer K C, Klatte J E, Dinh H V et al. Br J Dermatol 2008: 159: 1077-1085.
61. Kinori M, Kloepper J E, Paus R. Invest Ophthalmol Vis Sci 2011: 52: 4447-4458.
62. Billingham R E. Adv biol skin 1971: 11: 183-198.
63. Hill R P, Haycock J W, Jahoda C A. Exp Dermatol 2012: 21: 158-160.
64. Reynolds A J, Lawrence C, Cserhalmi-Friedman P B et al. Nature 1999: 402: 33-34.
65. Gilhar A, Etzioni A, Paus R. N Engl J Med 2012: 366: 1515-1525.
66. Harries M J, Paus R. Am J Pathol 2010: 177: 2152-2162.
67. Kang H, Wu W Y, Lo B K et al. J Invest Dermatol 2010: 130: 2677-2680.
68. Peters E M, Liotiri S, Bodo E et al. Am J Pathol 2007: 171: 1872-1886.
69. Kinori M, Bertolini M, Funk W et al. Exp Dermatol 2012: 21: 223-226.
70. Ito T, Ito N, Saathoff M et al. J Invest Dermatol 2005: 125: 1139-1148.
71. Christoph T, Muller-Rover S, Audring H et al. Br J Dermatol 2000: 142: 862-873.
72. Foitzik K, Lindner G, Mueller-Roever S et al. FASEB J 2000: 14: 752-760.
73. Dupasquier M, Stoitzner P, van Oudenaren A et al. J Invest Dermatol 2004: 123: 876-879.
74. Brown M A, Hatfield J K. Front Immunol 2012: 3: 147.
75. Sayed B A, Christy A, Quirion M R et al. Annu Rev Immunol 2008: 26: 705-739.
76. Waldmann H. Nature 2006: 442: 987-988.
77. Arck P C, Handjiski B, Kuhlmei A et al. J Mol Med (Berl) 2005: 83: 386-396.
78. Ito T, Ito N, Bettermann A et al. Am J Pathol 2004: 164: 623-634.
79. Xie Y, McElwee K J, Owen G R et al. J Invest Dermatol 2012: 132: 547-555.
80. Girardi M, Lewis J M, Filler R B et al. J Invest Dermatol 2006: 126: 808-814.
81. Havran W L, Jameson J M. J Immunol 2010: 184: 5423-5428.
82. Macleod A S, Havran W L. Cell Mol Life Sci 2011: 68: 2399-2408.
83. Stelekati E, Bahri R, D'Orlando O et al. Immunity 2009: 31: 665-676.
84. Arck P C, Handjiski B, Peters E M et al. Am J Pathol 2003: 162: 803-814.
85. Harvima I T, Nilsson G, Naukkarinen A. G Ital Dermatol Venereol 2010: 145: 195-204.
86. Paus R, Schmelz M, Biro T et al. J Clin Invest 2006: 116: 1174-1186.
87. Paus R, Theoharides T C, Arck P C. Trends Immunol 2006: 27: 32-39.
88. Paus R, Peters E M, Eichmuller S et al. J Investig Dermatol Symp Proc 1997: 2: 61-68.
89. Bertolini M, Gilhar A, Paus R. Exp Dermatol 2012: 21: 477-479.
90. Kaufman G, d'Ovidio R, Kaldawy A et al. Exp Dermatol 2010: 19: e347-349.
91. McElwee K, Gilhar A, Tobin D et al. Exp Dermatol 2013: in press.